Literature DB >> 8151396

Myocardial perfusion imaging with PET.

M Schwaiger1.   

Abstract

Although SPECT has become an accepted imaging technique for myocardial perfusion studies, there are several advantages to evaluating coronary artery disease (CAD) with PET. CAD is a complex, dynamic disease and quantitative measurements of myocardial blood flow by PET can improve the functional characterization of CAD. The major advantage of PET over SPECT is its ability to provide attenuation-corrected images, which decreases incidence of attenuation artifacts and increases specificity. Myocardial perfusion imaging with PET can also provide more accurate information on localization of disease, as well as quantitative assessment, in absolute values, of myocardial blood flow. The measurement of regional flow reserve allows for physiologic characterization of stenosis severity, and may provide early detection of CAD as well as prognostic information. The disadvantage of PET, compared to SPECT, is that the equipment and operations are more expensive. As more accurate diagnostic and prognostic data lead to improved patient management, the cost-to-benefit ratios of PET and SPECT in the clinical setting need to be further analyzed to determine which diagnostic test is most efficient in the work-up of patients with suspected or known CAD.

Entities:  

Mesh:

Year:  1994        PMID: 8151396

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  16 in total

Review 1.  The value of quantitative myocardial perfusion imaging with positron emission tomography in coronary artery disease.

Authors:  W Wijns; P G Camici
Journal:  Herz       Date:  1997-04       Impact factor: 1.443

2.  Steady-state free precession sequences in myocardial first-pass perfusion MR imaging: comparison with TurboFLASH imaging.

Authors:  Peter Hunold; Stefan Maderwald; Holger Eggebrecht; Florian M Vogt; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2003-11-26       Impact factor: 5.315

3.  Magnetic resonance perfusion imaging in patients with coronary artery disease: a qualitative approach.

Authors:  Penelope R Sensky; Nilesh J Samani; Christine Reek; Graham R Cherryman
Journal:  Int J Cardiovasc Imaging       Date:  2002-10       Impact factor: 2.357

4.  Novel and simple carbon-11-labeled ammonium salts as PET agents for myocardial perfusion imaging.

Authors:  Ohad Ilovich; Hana Billauer; Sharon Dotan; Nanette M T Freedman; Moshe Bocher; Eyal Mishani
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

Review 5.  Myocardial perfusion imaging by cardiac magnetic resonance.

Authors:  Juerg Schwitter
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 6.  Myocardial perfusion quantitation with PET: time to do our homework.

Authors:  Eva Fricke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

Review 7.  [Methods for coronary functional assessment].

Authors:  M Elsner
Journal:  Herz       Date:  1998-03       Impact factor: 1.443

Review 8.  Imaging of angiogenesis in cardiology.

Authors:  Takahiro Higuchi; Hans Juergen Wester; Markus Schwaiger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

9.  Synthesis and biodistribution of lipophilic and monocationic gallium radiopharmaceuticals derived from N,N'-bis(3-aminopropyl)-N,N'-dimethylethylenediamine: potential agents for PET myocardial imaging with 68Ga.

Authors:  Yui-May Hsiao; Carla J Mathias; Shiaw-Pyng Wey; Phillip E Fanwick; Mark A Green
Journal:  Nucl Med Biol       Date:  2009-01       Impact factor: 2.408

Review 10.  Diagnosing and characterizing coronary artery disease in women: developments in noninvasive and invasive imaging techniques.

Authors:  Vivian G Ng; Stephanie Meller; Suchith Shetty; Alexandra J Lansky
Journal:  J Cardiovasc Transl Res       Date:  2013-08-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.